Determinants of aspirin metabolism in healthy men and women: Effects of dietary inducers of UDP-glucuronosyltransferases

Journal of Nutrigenetics and Nutrigenomics

Volumn 4, Issue 2, 2011, Pages 110-118

  Navarro, Sandi L ^a   Saracino, Misty R ^a   Makar, Karen W ^a   Thomas, Sushma S ^a   Li, Lin ^a   Zheng, Yingye ^a   Levy, Lisa ^a   Schwarz, Yvonne ^a   Bigler, Jeannette ^a   Potter, John D ^a   Lampe, Johanna W ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

Aspirin; Citrus; Cruciferous vegetables; Glucuronidation; Soy; UDP glucuronosyltransferases

Indexed keywords

ACETYLSALICYLIC ACID; GLUCURONIDE; GLUCURONOSYLTRANSFERASE; PHENOLIC GLUCURONIDE; SALICYLIC ACID; SALICYLURIC ACID; UNCLASSIFIED DRUG;

ADULT; AFRICAN AMERICAN; ARTICLE; ASIAN; CAUCASIAN; DIET; DRUG EXCRETION; DRUG METABOLISM; ETHNICITY; FEMALE; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SEX DIFFERENCE; URINALYSIS; VEGETABLE;

ADULT; ASPIRIN; CROSS-SECTIONAL STUDIES; DIET; ENZYME INDUCTION; ETHNIC GROUPS; FEMALE; GENETIC ASSOCIATION STUDIES; GLUCURONIDES; GLUCURONOSYLTRANSFERASE; GLYCINE; HUMANS; MALE; MIDDLE AGED; NUTRIGENOMICS; SEX CHARACTERISTICS; YOUNG ADULT;

CITRUS;

EID: 79957538340     PISSN: 16616499     EISSN: 16616758     Source Type: Journal    
DOI: 10.1159/000327782     Document Type: Article

References (42)

1. Court M: Interindividual variability in hepatic drug glucuronidation: studies into the role of age, sex, enzyme inducers, and genetic polymorphism using the human liver bank as a model system. Drug Metab Rev 2010; 42: 202-217.
2. Needs CJ, Brooks PM: Clinical pharmacokinetics of the salicylates. Clin Pharmacokinet 1985; 10: 164-177. (Pubitemid 15104999)
3. Miaskiewicz SL, Shively CA, Vesell ES: Sex differences in absorption kinetics of sodium salicylate. Clin Pharmacol Ther 1982; 31: 30-37. (Pubitemid 12135805)
4. Lares-Asseff I, Juarez-Olguin H, Flores-Perez J, Guille-Perez A, Vargas A: Pharmacokinetics and metabolic rates of acetyl salicylic acid and its metabolites in an Otomi ethnic group of Mexico. Biol Pharm Bull 2004; 27: 706-709. (Pubitemid 41694676)
5. van Oijen M: Effect of genetic polymorphisms in UDP- glucuronosyltransferase 1A6 (UGT1A6) on acetylsalicylic acid metabolism in healthy female volunteers. Pharmacology 2009; 83: 237-242.
6. Chen Y, Kuehl GE, Bigler J, Rimorin CF, Schwarz Y, Shen DD, et al: UGT1A6 polymorphism and salicylic acid glucuronidation following aspirin. Pharmacogenet Genomics 2007; 17: 571-579. (Pubitemid 47057706)
7. Hutt AJ, Caldwell J, Smith RL: The metabolism of aspirin in man: a population study. Xenobiotica 1986; 16: 239-249. (Pubitemid 16164017)
8. Ciotti M, Marrone A, Potter C, Owens IS: Genetic polymorphism in the human UGT1A6 (planar phenol) UDP-glucuronosyltransferase: pharmacological implications. Pharmacogenetics 1997; 7: 485-495. (Pubitemid 27517577)
9. Bosma P, Chowdhury JR, Bakker C, Gantla S, de Boer N, Oostra BA, et al: The genetic basis of the reduced expression of bilirubin UDP- glucuronosyltransferase 1 in Gilberts syndrome. N Engl J Med 1995; 333: 1171-1175.
10. Guillemette C, Millikan RC, Newman B, Housman DE: Genetic polymorphisms in uridine diphospho-glucuronosyltransferase 1A1 and association with breast cancer among African Americans. Cancer Res 2000; 60: 950-956. (Pubitemid 30129531)
11. Nagar S, Zalatoris JJ, Blanchard RL: Human UGT1A6 pharmacogenetics: identification of a novel SNP, characterization of allele frequencies and functional analysis of recombinant allozymes in human liver tissue and in cultured cells. Pharmacogenetics 2004; 14: 487-499. (Pubitemid 39100001)
12. Krishnaswamy S, Hao Q, Al-Rohaimi A, Hesse LM, von Moltke LL, Greenblatt DJ, et al: UDP glucuronosyltransferase (UGT) 1A6 pharmacogenetics: II. Functional impact of the three most common nonsynonymous UGT1A6 polymorphisms (S7A, T181A, and R184S). J Pharmacol Exp Ther 2005; 313: 1340-1346. (Pubitemid 40727040)
13. Lampe JW, Bigler J, Horner NK, Potter JD: UDP-glucuronosyltransferase (UGT1A1*28 and UGT1A6*2) polymorphisms in Caucasians and Asians: relationships to serum bilirubin concentrations. Pharmacogenetics 1999; 9: 341-349. (Pubitemid 29376378)
14. Bigler J, Whitton J, Lampe JW, Fosdick L, Bostick RM, Potter JD: CYP2C9 and UGT1A6 genotypes modulate the protective effect of aspirin on colon adenoma risk. Cancer Res 2001; 61: 3566-3569. (Pubitemid 32694961)
15. Levine RR: Pharmacology: Drug Actions and Reactions, ed 6. New York, Parthenon, 2000.
16. Saracino MR, Bigler J, Schwarz Y, Chang JL, Li S, Li L, et al: Citrus fruit intake is associated with lower serum bilirubin concentration among women with the UGT1A1*28 polymorphism. J Nutr 2009; 139: 555-560.
17. Navarro SL, Peterson S, Chen C, Makar KW, Schwarz Y, King IB, et al: Cruciferous vegetable feeding alters UGT1A1 activity: diet- and genotype-dependent changes in serum bilirubin in a controlled feeding trial. Cancer Prev Res 2009; 2: 345-352.
18. Saracino MR, Lampe JW: Phytochemical regulation of UDP- glucuronosyltransferases: implications for cancer prevention. Nutr Cancer 2007; 59: 121-141. (Pubitemid 350230730)
19. Dinkova-Kostova AT, Holtzclaw WD, Wakabayashi N: Keap1, the sensor for electrophiles and oxidants that regulates the phase 2 response, is a zinc metalloprotein. Biochemistry 2005; 44: 6889-6899. (Pubitemid 40632407)
20. Lampe JW, Peterson S: Brassica, biotransformation and cancer risk: genetic polymorphisms alter the preventive effects of cruciferous vegetables. J Nutr 2002; 132: 2991-2994.
21. Nho CW, Jeffery E: The synergistic upregulation of phase II detoxification enzymes by glucosinolate breakdown products in cruciferous vegetables. Toxicol Appl Pharmacol 2001; 174: 146-152. (Pubitemid 32675517)
22. Willett W: Nutritional Epidemiology, ed 2. New York, Oxford University Press, 1998.
23. Liu JH, Smith PC: Direct analysis of salicylic acid, salicyl acyl glucuronide, salicyluric acid and gentisic acid in human plasma and urine by high-performance liquid chromatography. J Chromatogr B Biomed Appl 1996; 675: 61-70. (Pubitemid 26038755)
24. Ho KY, Evans WS, Blizzard RM, Veldhuis JD, Merriam GR, Samojlik E, et al: Effects of sex and age on the 24-hour profile of growth hormone secretion in man: importance of endogenous estradiol concentrations. J Clin Endocrinol Metab 1987; 64: 51-58. (Pubitemid 17015877)
25. Miners JO, Grgurinovich N, Whitehead AG, Robson RA, Birkett DJ: Influence of gender and oral contraceptive steroids on the metabolism of salicylic acid and acetylsalicylic acid. Br J Clin Pharmacol 1986; 22: 135-142. (Pubitemid 17174109)
26. Anderson GD: Sex differences in drug metabolism: cytochrome P-450 and uridine diphosphate glucuronosyltransferase. J Gend Specif Med 2002; 5: 25-33. (Pubitemid 34467386)
27. Gupta KC, Joshi JV, Hazari K, Pohujani SM, Satoskar RS: Effect of low estrogen combination oral contraceptive on metabolism of aspirin and phenylbutazone. Int J Clin Pharmacol Ther Toxicol 1982; 20: 511-513. (Pubitemid 12002855)
28. Anderson GD: Gender differences in pharmacological response. Int Rev Neurobiol 2008; 83: 1-10.
29. Furst DE, Gupta N, Paulus HE: Salicylate metabolism in twins. Evidence suggesting a genetic influence and induction of salicylurate formation. J Clin Invest 1977; 60: 32-42. (Pubitemid 8145141)
30. Williams FM, Nicholson EN, Woolhouse NW, Adjepon-Yamoah KK, Rawlins MD: Activity of esterases in plasma from Ghanaian and British subjects. Eur J Clin Pharmacol 1986; 31: 485-489. (Pubitemid 17018791)
31. Knights KM, Sykes MJ, Miners JO: Amino acid conjugation: contribution to the metabolism and toxicity of xenobiotic carboxylic acids. Expert Opin Drug Metab Toxicol 2007; 3: 159-168. (Pubitemid 47316038)
32. Yamamoto A, Nonen S, Fukuda T, Yamazaki H, Azuma J: Genetic polymorphisms of glycine N-acyltransferase in Japanese individuals. Drug Metab Pharmacokinet 2009; 24: 114-117.
33. Levy G, Tsuchiya T, Amsel LP: Limited capacity for salicyl phenolic glucuronide formation and its effect on the kinetics of salicylate elimination in man. Clin Pharmacol Ther 1972; 13: 258-268.
34. Gregus Z, Fekete T, Varga F, Klaassen CD: Availability of glycine and coenzyme A limits glycine conjugation in vivo. Drug Metab Dispos 1992; 20: 234-240.
35. Campbell L, Wilson HK, Samuel AM, Gompertz D: Interactions of m-xylene and aspirin metabolism in man. Br J Ind Med 1988; 45: 127-132. (Pubitemid 18065643)
36. Mackenzie PI, Bock KW, Burchell B, Guillemette C, Ikushiro S, Iyanagi T, et al: Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. Pharmacogenet Genomics 2005; 15: 677-685. (Pubitemid 41345319)
37. Thomas SS, Li SS, Lampe JW, Potter JD, Bigler J: Genetic variability, haplotypes, and htSNPs for exons 1 at the human UGT1A locus. Hum Mutat 2006; 27: 717.
38. Kuehl GE, Lampe JW, Potter JD, Bigler J: Glucuronidation of nonsteroidal anti-inflammatory drugs: identifying the enzymes responsible in human liver microsomes. Drug Metab Dispos 2005; 33: 1027-1035. (Pubitemid 41002785)
39. Maruo Y, Iwai M, Mori A, Sato H, Takeuchi Y: Polymorphism of UDP-glucuronosyltransferase and drug metabolism. Curr Drug Metab 2005; 6: 91-99. (Pubitemid 40394338)
40. Chan AT, Tranah GJ, Giovannucci EL, Hunter DJ, Fuchs CS: Genetic variants in the UGT1A6 enzyme, aspirin use, and the risk of colorectal adenoma. J Natl Cancer Inst 2005; 97: 457-460. (Pubitemid 40528609)
41. McGreavey LE, Turner F, Smith G, Boylan K, Timothy Bishop D, Forman D, et al: No evidence that polymorphisms in CYP2C8, CYP2C9, UGT1A6, PPARdelta and PPARgamma act as modifiers of the protective effect of regular NSAID use on the risk of colorectal carcinoma. Pharmacogenet Genomics 2005; 15: 713-721. (Pubitemid 41345323)
42. Kristal AR, Vizenor NC, Patterson RE, Neuhouser ML, Shattuck AL, McLerran D: Precision and bias of food frequency- based measures of fruit and vegetable intakes. Cancer Epidemiol Biomarkers Prev 2000; 9: 939-944.